DK3556869T3 - Sammensætninger og fremgangsmåder til sekventering af polynukleotider - Google Patents

Sammensætninger og fremgangsmåder til sekventering af polynukleotider Download PDF

Info

Publication number
DK3556869T3
DK3556869T3 DK19161148.2T DK19161148T DK3556869T3 DK 3556869 T3 DK3556869 T3 DK 3556869T3 DK 19161148 T DK19161148 T DK 19161148T DK 3556869 T3 DK3556869 T3 DK 3556869T3
Authority
DK
Denmark
Prior art keywords
polynucleotides
compositions
sequence
methods
Prior art date
Application number
DK19161148.2T
Other languages
English (en)
Inventor
Eric Stava
Jens H Gundlach
Jeffrey G Mandell
Kevin L Gunderson
Ian M Derrington
Hosein Himani
Original Assignee
Illumina Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Illumina Inc filed Critical Illumina Inc
Application granted granted Critical
Publication of DK3556869T3 publication Critical patent/DK3556869T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416Systems
    • G01N27/447Systems using electrophoresis
DK19161148.2T 2013-11-26 2014-11-26 Sammensætninger og fremgangsmåder til sekventering af polynukleotider DK3556869T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361909316P 2013-11-26 2013-11-26
EP14830903.2A EP3074534B1 (en) 2013-11-26 2014-11-26 Methods for polynucleotide sequencing

Publications (1)

Publication Number Publication Date
DK3556869T3 true DK3556869T3 (da) 2023-10-02

Family

ID=52424089

Family Applications (2)

Application Number Title Priority Date Filing Date
DK14830903.2T DK3074534T3 (da) 2013-11-26 2014-11-26 Fremgangsmåder til polynukleotidsekventering
DK19161148.2T DK3556869T3 (da) 2013-11-26 2014-11-26 Sammensætninger og fremgangsmåder til sekventering af polynukleotider

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK14830903.2T DK3074534T3 (da) 2013-11-26 2014-11-26 Fremgangsmåder til polynukleotidsekventering

Country Status (12)

Country Link
US (4) US9689033B2 (da)
EP (3) EP3556869B1 (da)
JP (3) JP6800749B2 (da)
CN (2) CN113528632A (da)
AU (3) AU2014354726B2 (da)
CA (2) CA2926871C (da)
DK (2) DK3074534T3 (da)
ES (2) ES2958715T3 (da)
FI (1) FI3556869T3 (da)
LT (1) LT3074534T (da)
SI (1) SI3074534T1 (da)
WO (2) WO2015081178A1 (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3269825B1 (en) * 2011-09-23 2020-02-19 Oxford Nanopore Technologies Limited Analysis of a polymer comprising polymer units
CN104321441B (zh) 2012-02-16 2016-10-19 牛津楠路珀尔科技有限公司 聚合物的测量的分析
US9777049B2 (en) 2012-04-10 2017-10-03 Oxford Nanopore Technologies Ltd. Mutant lysenin pores
GB201222928D0 (en) 2012-12-19 2013-01-30 Oxford Nanopore Tech Ltd Analysis of a polynucleotide
GB201313477D0 (en) 2013-07-29 2013-09-11 Univ Leuven Kath Nanopore biosensors for detection of proteins and nucleic acids
WO2015081178A1 (en) * 2013-11-26 2015-06-04 Illumina, Inc. Compositions and methods for polynucleotide sequencing
AU2015208919B9 (en) 2014-01-22 2021-04-01 Oxford Nanopore Technologies Limited Method for attaching one or more polynucleotide binding proteins to a target polynucleotide
US10359395B2 (en) 2014-02-19 2019-07-23 University Of Washington Nanopore-based analysis of protein characteristics
CN106574300A (zh) 2014-05-02 2017-04-19 牛津纳米孔技术公司 改善目标多核苷酸相对于跨膜孔移动的方法
WO2016059427A1 (en) * 2014-10-16 2016-04-21 Oxford Nanopore Technologies Limited Analysis of a polymer
EP3334840A1 (en) * 2015-08-10 2018-06-20 Stratos Genomics, Inc. Single molecule nucleic acid sequencing with molecular sensor complexes
CN108521782A (zh) * 2015-10-21 2018-09-11 豪夫迈·罗氏有限公司 含氟聚合物作为疏水层以支持用于纳米孔的脂质双层形成的用途
WO2017149317A1 (en) 2016-03-02 2017-09-08 Oxford Nanopore Technologies Limited Mutant pore
EP4122949A1 (en) 2016-04-06 2023-01-25 Oxford Nanopore Technologies plc Mutant pore
JP2019521055A (ja) 2016-04-14 2019-07-25 ロッキード・マーチン・コーポレーション グラフェン欠陥の選択的界面緩和
EP3475447B1 (en) 2016-06-23 2021-04-21 F. Hoffmann-La Roche AG Formation and calibration of nanopore sequencing cells
CN109952382B (zh) 2016-08-08 2023-11-14 豪夫迈·罗氏有限公司 随机测序方法的碱基识别
PT3529380T (pt) 2016-10-19 2022-08-31 Illumina Inc Métodos para ligação química de ácidos nucléicos
EP4273156A3 (en) 2017-06-30 2024-01-17 Vib Vzw Novel protein pores
AU2018331533B2 (en) * 2017-09-15 2021-10-28 Illumina, Inc. Sequence-detection system
WO2019055856A1 (en) * 2017-09-15 2019-03-21 Illumina, Inc. ACCORDING AND CALIBRATION CHARACTERISTICS OF A SEQUENCE DETECTION SYSTEM
US10310959B2 (en) 2017-11-07 2019-06-04 Bank Of America Corporation Pre-deployment validation system using intelligent databases
WO2019243421A1 (en) * 2018-06-21 2019-12-26 F. Hoffmann-La Roche Ag Tunneling junctions for sequencing
US20190390268A1 (en) * 2018-06-26 2019-12-26 Electronic Biosciences, Inc. Controlled nanopore translocation utilizing extremophilic replication proteins
JP2020031557A (ja) * 2018-08-28 2020-03-05 株式会社日立ハイテクノロジーズ 生体分子分析装置
WO2020084705A1 (ja) * 2018-10-24 2020-04-30 株式会社日立ハイテク 生体ポリマ分析デバイス及びそれを用いた分析装置、並びに分析方法
WO2021056598A1 (zh) 2019-09-29 2021-04-01 北京齐碳科技有限公司 一种Mmup单体变体及其应用
CN114807317A (zh) * 2021-01-22 2022-07-29 上海羿鸣生物科技有限公司 一种优化的dna线性扩增方法及试剂盒
GB202107192D0 (en) * 2021-05-19 2021-06-30 Oxford Nanopore Tech Ltd Method
CN113322180B (zh) * 2021-05-31 2022-07-15 中国科学院物理研究所 基于纳米孔测序的力谱分析方法和分析装置
US20230298693A1 (en) * 2022-02-28 2023-09-21 Rajant Health Incorporated Alignment-free variant calling

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4469863A (en) 1980-11-12 1984-09-04 Ts O Paul O P Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
US5034506A (en) 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
US5235033A (en) 1985-03-15 1993-08-10 Anti-Gene Development Group Alpha-morpholino ribonucleoside derivatives and polymers thereof
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5216141A (en) 1988-06-06 1993-06-01 Benner Steven A Oligonucleotide analogs containing sulfur linkages
US5386023A (en) 1990-07-27 1995-01-31 Isis Pharmaceuticals Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling
US5602240A (en) 1990-07-27 1997-02-11 Ciba Geigy Ag. Backbone modified oligonucleotide analogs
US5644048A (en) 1992-01-10 1997-07-01 Isis Pharmaceuticals, Inc. Process for preparing phosphorothioate oligonucleotides
US5637684A (en) 1994-02-23 1997-06-10 Isis Pharmaceuticals, Inc. Phosphoramidate and phosphorothioamidate oligomeric compounds
US5508179A (en) 1994-03-18 1996-04-16 Bio-Rad Laboratories, Inc. Use of deoxyribose nicotinamide adenine dinucleotide to enhance the specificity of NAD+ -dependent ligation reactions
US5795782A (en) 1995-03-17 1998-08-18 President & Fellows Of Harvard College Characterization of individual polymer molecules based on monomer-interface interactions
EP1192453B1 (en) 1999-06-22 2012-02-15 President and Fellows of Harvard College Molecular and atomic scale evaluation of biopolymers
US7582420B2 (en) 2001-07-12 2009-09-01 Illumina, Inc. Multiplex nucleic acid reactions
US7955794B2 (en) 2000-09-21 2011-06-07 Illumina, Inc. Multiplex nucleic acid reactions
US6913884B2 (en) 2001-08-16 2005-07-05 Illumina, Inc. Compositions and methods for repetitive use of genomic DNA
WO2001057269A2 (en) 2000-02-07 2001-08-09 Illumina, Inc. Nucleic acid detection methods using universal priming
GB0505971D0 (en) 2005-03-23 2005-04-27 Isis Innovation Delivery of molecules to a lipid bilayer
US20100196203A1 (en) 2007-02-20 2010-08-05 Gurdial Singh Sanghera Formation of Lipid Bilayers
CN103695530B (zh) 2008-07-07 2016-05-25 牛津纳米孔技术有限公司 酶-孔构建体
EP3029467B1 (en) 2008-09-22 2020-01-08 University of Washington Msp nanopores and related methods
GB0905140D0 (en) * 2009-03-25 2009-05-06 Isis Innovation Method
WO2012033524A2 (en) * 2010-09-07 2012-03-15 The Regents Of The University Of California Control of dna movement in a nanopore at one nucleotide precision by a processive enzyme
EP2737536B1 (en) 2011-07-27 2018-05-09 The Board of Trustees of the University of Illionis Nanopore sensors for biomolecular characterization
JP6226869B2 (ja) 2011-10-21 2017-11-08 オックスフォード ナノポール テクノロジーズ リミテッド 酵素法
US9617591B2 (en) 2011-12-29 2017-04-11 Oxford Nanopore Technologies Ltd. Method for characterising a polynucleotide by using a XPD helicase
AU2012360244B2 (en) 2011-12-29 2018-08-23 Oxford Nanopore Technologies Limited Enzyme method
JP5809572B2 (ja) 2012-01-30 2015-11-11 ルネサスエレクトロニクス株式会社 半導体装置
US9777049B2 (en) 2012-04-10 2017-10-03 Oxford Nanopore Technologies Ltd. Mutant lysenin pores
WO2013185137A1 (en) * 2012-06-08 2013-12-12 Pacific Biosciences Of California, Inc. Modified base detection with nanopore sequencing
CA2879261C (en) * 2012-07-19 2022-12-06 Oxford Nanopore Technologies Limited Modified helicases
WO2015081178A1 (en) * 2013-11-26 2015-06-04 Illumina, Inc. Compositions and methods for polynucleotide sequencing

Also Published As

Publication number Publication date
AU2014354726B2 (en) 2020-03-12
AU2020202489A1 (en) 2020-05-07
JP2021040646A (ja) 2021-03-18
JP7349972B2 (ja) 2023-09-25
EP4282983A2 (en) 2023-11-29
JP2023116553A (ja) 2023-08-22
US10364462B2 (en) 2019-07-30
CN105934522B (zh) 2021-07-20
US20150152495A1 (en) 2015-06-04
DK3074534T3 (da) 2019-07-29
EP3556869A1 (en) 2019-10-23
EP3556869B1 (en) 2023-08-02
AU2020202489B2 (en) 2022-06-23
JP2017503473A (ja) 2017-02-02
CN113528632A (zh) 2021-10-22
JP6800749B2 (ja) 2020-12-23
ES2735015T3 (es) 2019-12-13
CA2926871A1 (en) 2015-06-04
US20210355534A1 (en) 2021-11-18
ES2958715T3 (es) 2024-02-13
SI3074534T1 (sl) 2019-08-30
US20170268055A1 (en) 2017-09-21
LT3074534T (lt) 2019-08-26
US11041196B2 (en) 2021-06-22
US11879155B2 (en) 2024-01-23
WO2015081211A3 (en) 2015-08-06
EP4282983A3 (en) 2024-02-28
US9689033B2 (en) 2017-06-27
WO2015081178A1 (en) 2015-06-04
EP3074534B1 (en) 2019-05-01
US20200024657A1 (en) 2020-01-23
CN105934522A (zh) 2016-09-07
FI3556869T3 (fi) 2023-09-28
CA2926871C (en) 2022-08-16
EP3074534A1 (en) 2016-10-05
WO2015081211A2 (en) 2015-06-04
AU2014354726A1 (en) 2016-06-02
CA3157586A1 (en) 2015-06-04
AU2022231786A1 (en) 2022-10-13

Similar Documents

Publication Publication Date Title
DK3556869T3 (da) Sammensætninger og fremgangsmåder til sekventering af polynukleotider
DK3008168T3 (da) Sc-celler og sammensætninger og fremgangsmåde til dannelse deraf
DK3594348T3 (da) Kort c/ebp-alpha til aktivering af rna-sammensætninger og anvendelsesfremgangsmåder
DK3611262T3 (da) Fremgangsmåder til sekvensering af immunrepertoire
DK2970456T3 (da) Fremgangsmåder og sammensætninger til levering af mrna-kodede antistoffer
DK2961831T3 (da) Sammensætninger og fremgangsmåder til immunterapi
DK3080274T3 (da) Fremgangsmåder og sammensætninger til genom-manipulation
DK3261721T3 (da) Anvendelse af pridopidin til forbedring af hukommelse
DK3252160T3 (da) Systemer, fremgangsmåder og sammensætninger med crispr-cas-bestanddele til sekvensmanipulation
DK3071215T3 (da) Sammensætninger og fremgangsmåder til behandling af pulmonal hypertension
DK2972353T3 (da) Forbedrede fremgangsmåder til udførelse af multipleksanalyser
DK3071046T3 (da) Fremgangsmåde til ekstraktion af ærteproteiner
DK2978419T3 (da) Sammensætninger til forbedring af cellelevedygtighed og fremgangsmåder til anvendelse deraf
DK3044320T3 (da) Sekretion af hæmholdige polypeptider
DK3007695T3 (da) Sammensætninger og fremgangsmåder til behandling af anæmi
DK2929031T5 (da) Pcsk9-irna-sammensætninger og fremgangsmåder til anvendelse deraf
DK2984166T3 (da) Sammensætninger til behandling af mpsi
DK3144001T3 (da) Sammensætninger af selenoorganiske forbindelser og fremgangsmåder til anvendelse deraf
DK3300610T3 (da) Fremgangsmåde til fraktionering af opløselige ærter
DK3393655T3 (da) Fenfluramin-sammensætninger og fremgangsmåder til fremstilling af samme
DK2994533T3 (da) Fremgangsmåder og sammensætninger til behandling af cancer
DK3363805T3 (da) Fremgangsmåder til syntese af sphingomyeliner og dihydrosphingomyeliner
DK3065771T3 (da) Fremgangsmåder og sammensætninger til vedvarende immunterapi
DK2924093T3 (da) Multicarboxylat-sammensætninger og fremgangsmåde til fremstilling af disse
DK3033081T3 (da) Sammensætninger og fremgangsmåder til behandling af kronisk urticaria